Man-Man Han1,2, Xiang-Yun Zhu1,2, You-Fan Peng1,2, Hao Lin2,3, De-Chen Liu2,3, Ling Li1,2. 1. Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China. 2. Pancreatic Research Institute, Southeast University, Nanjing 210009, China. 3. Department of Clinical Science and Research, School of Medicine, Zhongda Hospital, Southeast University, Nanjing 210009, China.
Abstract
BACKGROUND: The changes of intestinal microbiome are associated with inflammatory, metabolic, and malignant disorders, and there are no studies assessing the intestinal microbiota of mice with chronic pancreatitis (CP). Thus, we aim to investigate the variations in diversity, composition and function of intestinal microbiota in CP mice. METHODS: Sixteen male C57BL/6 mice were randomly selected, and divided into two groups, treated intraperitoneally with saline (normal control group, CT group) or ethanol + cerulein (experimental group, CP group) for 6 weeks. Body weight as measured in entire processes. Histopathological examination of CP index was conducted to verify the CP induction. Extracted DNA from colon samples was used for Illumina HiSeq sequencing of the bacterial V4 region of 16S rRNA gene and analyzed using Quantitative Insights Into Microbial Ecology (QIIME). Functional profiling of microbial communities was predicted with BugBase. RESULTS: Significant alterations of the gut microbiota were found in the CP mice compared to CT groups, as revealed by significant decrease in bacterial richness and diversity, declined the relative abundance of Lachnospiraceae_NK4A136, Ruminiclostridium and Roseburia, and increased the relative abundances of Bacteroides and Alloprevotella genera. Analysis of microbial community-level phenotypes revealed significant differences in nine phenotypes (aerobic, anaerobic, containing mobile elements, facultatively anaerobic, biofilm forming, gram-negative, gram-positive, potentially pathogenic, and stress tolerant) between CP group and CT group. CONCLUSIONS: This study indicated that mice with CP had a distinct microbiota profile. 2019 Annals of Translational Medicine. All rights reserved.
BACKGROUND: The changes of intestinal microbiome are associated with inflammatory, metabolic, and malignant disorders, and there are no studies assessing the intestinal microbiota of mice with chronic pancreatitis (CP). Thus, we aim to investigate the variations in diversity, composition and function of intestinal microbiota in CP mice. METHODS: Sixteen male C57BL/6 mice were randomly selected, and divided into two groups, treated intraperitoneally with saline (normal control group, CT group) or ethanol + cerulein (experimental group, CP group) for 6 weeks. Body weight as measured in entire processes. Histopathological examination of CP index was conducted to verify the CP induction. Extracted DNA from colon samples was used for Illumina HiSeq sequencing of the bacterial V4 region of 16S rRNA gene and analyzed using Quantitative Insights Into Microbial Ecology (QIIME). Functional profiling of microbial communities was predicted with BugBase. RESULTS: Significant alterations of the gut microbiota were found in the CP mice compared to CT groups, as revealed by significant decrease in bacterial richness and diversity, declined the relative abundance of Lachnospiraceae_NK4A136, Ruminiclostridium and Roseburia, and increased the relative abundances of Bacteroides and Alloprevotella genera. Analysis of microbial community-level phenotypes revealed significant differences in nine phenotypes (aerobic, anaerobic, containing mobile elements, facultatively anaerobic, biofilm forming, gram-negative, gram-positive, potentially pathogenic, and stress tolerant) between CP group and CT group. CONCLUSIONS: This study indicated that mice with CP had a distinct microbiota profile. 2019 Annals of Translational Medicine. All rights reserved.
Entities:
Keywords:
Chronic pancreatitis (CP); community diversity; high-throughput sequencing; microbial phenotypes
Authors: A Andoh; T Tsujikawa; M Sasaki; K Mitsuyama; Y Suzuki; T Matsui; T Matsumoto; Y Benno; Y Fujiyama Journal: Aliment Pharmacol Ther Date: 2008-09-26 Impact factor: 8.171
Authors: Berglind A Magnusdottir; Maria B Baldursdottir; Evangelos Kalaitzakis; Einar S Björnsson Journal: Scand J Gastroenterol Date: 2019-01-31 Impact factor: 2.423
Authors: D Mariat; O Firmesse; F Levenez; Vd Guimarăes; H Sokol; J Doré; G Corthier; J-P Furet Journal: BMC Microbiol Date: 2009-06-09 Impact factor: 3.605
Authors: Daniel de la Iglesia-García; Wei Huang; Peter Szatmary; Iria Baston-Rey; Jaime Gonzalez-Lopez; Guillermo Prada-Ramallal; Rajarshi Mukherjee; Quentin M Nunes; J Enrique Domínguez-Muñoz; Robert Sutton Journal: Gut Date: 2016-12-09 Impact factor: 23.059
Authors: L Xia; Z Xu; X Zhou; F Bergmann; N Grabe; M W Büchler; J P Neoptolemos; T Hackert; G Kroemer; F Fortunato Journal: Cell Death Dis Date: 2020-10-21 Impact factor: 8.469